Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cancer Medicine|June 3, 2024
Real-world study on the characteristics, post-nephrectomy journey, and outcomes of patients with early-stage renal cell carcinoma based on risk groupsJose A Karam, Rituparna Bhattacharya, Adesuwa Ogbomo, et al.
Pragmatic and Observational Research|April 25, 2019
Using claims data to attribute patients with breast, lung, or colorectal cancer to prescribing oncologistsEzra Fishman, John Barron, Ying Liu, et al.
Health Affairs (Project Hope)|August 9, 2017
Offering A Price Transparency Tool Did Not Reduce Overall Spending Among California Public Employees And RetireesSunita Desai, Laura A Hatfield, Andrew L Hicks, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2009
Development of aliphatic biodegradable photoluminescent polymersJian Yang, Yi Zhang, Santosh Gautam, et al.
The Pediatric Infectious Disease Journal|November 9, 2018
Variation in Outpatient Antibiotic Dispensing for Respiratory Infections in Children by Clinician Specialty and Treatment SettingAbiy Agiro, Santosh Gautam, Eric Wall, et al.
Breast Cancer Research and Treatment|June 13, 2023
Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2- MBC in the real worldMegan Kruse, Emily Nash Smyth, Lee Bowman, et al.
Frontiers in Oncology|May 8, 2026
Front-line treatment approaches in multiple myeloma: real-world data from a community-based oncology networkR Steve Paulson, Santosh Gautam, Rohan Medhekar, et al.
Cancer Medicine|November 1, 2024
Comparison of Time to Next Treatment or Death Between Front-Line Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Bortezomib, Lenalidomide, and Dexamethasone (VRd) Among Transplant-Ineligible Patients With Multiple MyelomaDoris K Hansen, Santosh Gautam, Marie-Hélène Lafeuille, et al.
Hematological Oncology|April 10, 2025
Daratumumab, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide, and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Meta-AnalysisLucio N Gordan, Rohan Medhekar, Alex Z Fu, et al.
Pageof 3